Paper139409
Mechanism of action of choleragen. Evidence for ADP-ribosyltransferase activity with arginine as an acceptor.
Moss J and 1 other. J Biol Chem, 1977. Cited by 335 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Mechanism of action of choleragen. Evidence for ADP-ribosyltransferase activity with arginine as an acceptor. Papers, record 139409. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/139409
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Mechanism of action of choleragen. Evidence for ADP-ribosyltransferase activity with arginine as an acceptor.
- PubMed
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Bacterial Toxins | Major topic |
| Pentosyltransferases | Major topic |
| Vibrio cholerae | Major topic |
| Adenosine Diphosphate Sugars | |
| Arginine | |
| Binding Sites | |
| Niacinamide | |
| Protein Binding | |
| Ribose |
Source PubMed
Cited by80
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 335 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40,273,333 | Kinetic Mechanism of the Emergent Anticancer Target, Human ADP-ribosyltransferase 1. | Biochemistry | 2025 | https://conductscience.org/library/papers/40273333 | PubMed |
| 39,637,178 | Administration of novobiocin and apomorphine mitigates cholera toxin mediated cellular toxicity: Lessons from cholera toxin yeast model system. | PLoS One | 2024 | https://conductscience.org/library/papers/39637178 | PubMed |
| 39,591,223 | An Emerging Way for Bacteria to Engage with Host Cells via Protein ADP-riboxanation. | Toxins (Basel) | 2024 | https://conductscience.org/library/papers/39591223 | PubMed |
| 39,145,455 | The forgotten pandemic: how understanding cholera illuminated mechanisms of chloride channels in multiple diseases. | J Clin Invest | 2024 | https://conductscience.org/library/papers/39145455 | PubMed |
| 37,939,374 | Synthetic Dual Cysteine-ADP Ribosylated Peptides from the Androgen Receptor are Recognized by the DTX3L/PARP9 Complex. | ACS Chem Biol | 2023 | https://conductscience.org/library/papers/37939374 | PubMed |
| 36,497,109 | ARH Family of ADP-Ribose-Acceptor Hydrolases. | Cells | 2022 | https://conductscience.org/library/papers/36497109 | PubMed |
| 35,175,282 | Beyond protein modification: the rise of non-canonical ADP-ribosylation. | Biochem J | 2022 | https://conductscience.org/library/papers/35175282 | PubMed |
| 34,969,853 | PKD-dependent PARP12-catalyzed mono-ADP-ribosylation of Golgin-97 is required for E-cadherin transport from Golgi to plasma membrane. | Proc Natl Acad Sci U S A | 2022 | https://conductscience.org/library/papers/34969853 | PubMed |
| 32,966,781 | Mapping Physiological ADP-Ribosylation Using Activated Ion Electron Transfer Dissociation. | Cell Rep | 2020 | https://conductscience.org/library/papers/32966781 | PubMed |
| 32,092,898 | ARH1 in Health and Disease. | Cancers (Basel) | 2020 | https://conductscience.org/library/papers/32092898 | PubMed |
| 30,798,302 | An Advanced Strategy for Comprehensive Profiling of ADP-ribosylation Sites Using Mass Spectrometry-based Proteomics. | Mol Cell Proteomics | 2019 | https://conductscience.org/library/papers/30798302 | PubMed |
| 29,043,790 | Emissive Synthetic Cofactors: An Isomorphic, Isofunctional, and Responsive NAD+ Analogue. | J Am Chem Soc | 2017 | https://conductscience.org/library/papers/29043790 | PubMed |
| 23,382,240 | Arginine ADP-ribosylation mechanism based on structural snapshots of iota-toxin and actin complex. | Proc Natl Acad Sci U S A | 2013 | https://conductscience.org/library/papers/23382240 | PubMed |
| 22,879,887 | Arginine-specific mono ADP-ribosylation in vitro of antimicrobial peptides by ADP-ribosylating toxins. | PLoS One | 2012 | https://conductscience.org/library/papers/22879887 | PubMed |
| 19,897,717 | ADP-ribosylation of human defensin HNP-1 results in the replacement of the modified arginine with the noncoded amino acid ornithine. | Proc Natl Acad Sci U S A | 2009 | https://conductscience.org/library/papers/19897717 | PubMed |
| 19,895,577 | Side chain specificity of ADP-ribosylation by a sirtuin. | FEBS J | 2009 | https://conductscience.org/library/papers/19895577 | PubMed |
| 19,744,927 | Identification of an iron-sulfur cluster that modulates the enzymatic activity in NarE, a Neisseria meningitidis ADP-ribosyltransferase. | J Biol Chem | 2009 | https://conductscience.org/library/papers/19744927 | PubMed |
| 17,707,545 | "Alternative" endocytic mechanisms exploited by pathogens: new avenues for therapeutic delivery? | Adv Drug Deliv Rev | 2007 | https://conductscience.org/library/papers/17707545 | PubMed |
| 17,526,733 | Enhanced sensitivity to cholera toxin in ADP-ribosylarginine hydrolase-deficient mice. | Mol Cell Biol | 2007 | https://conductscience.org/library/papers/17526733 | PubMed |
| 17,146,673 | C3 exoenzymes, novel insights into structure and action of Rho-ADP-ribosylating toxins. | Naunyn Schmiedebergs Arch Pharmacol | 2007 | https://conductscience.org/library/papers/17146673 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/139409
GET https://conductscience.org/api/papers/v1/139409/cited_by?page=2